芬兰前列腺癌筛查随机研究中血清胆固醇与前列腺癌风险
该研究在芬兰前列腺癌筛查随机研究(FinRSPC)嵌套人群中分析血脂参数与前列腺癌风险。中位随访17年,17,696名男性中诊断2,404例前列腺癌。总胆固醇最高三分位(>5.1 mmol/L)和LDL>3 mmol/L与Gleason 8-10癌风险升高相关;3年滞后分析中总胆固醇和HDL升高与总体风险增加相关,但20年滞后时总胆固醇最高三分位与风险降低相关。他汀使用未改变风险关联。
要点
- 总胆固醇>5.1 mmol/L与Gleason 8-10前列腺癌风险升高相关(HR 1.42)。
- LDL>3 mmol/L与Gleason 8-10前列腺癌风险升高相关(HR 1.38)。
- 3年滞后分析中总胆固醇和HDL升高与总体前列腺癌风险增加相关。
核心结论
- 高胆固醇血症可能在短期内增加总体前列腺癌风险,但20年滞后时观察到反向关联。
- HDL升高也观察到类似的总体前列腺癌风险增加,与既往研究结果矛盾。
- 他汀使用未改变血脂参数与前列腺癌的风险关联。
研究设计与样本
- 研究为芬兰前列腺癌筛查随机研究(FinRSPC)的嵌套人群分析。
- 共纳入17,696名有胆固醇测量数据的男性,中位随访17年,诊断2,404例前列腺癌。
- 采用Cox回归模型估计风险比(HR)及95%置信区间(95%CI),并按Gleason分级和肿瘤分期分层。
主要发现
- 总胆固醇最高三分位(>5.1 mmol/L)与Gleason 8-10癌风险升高相关(HR 1.42,95%CI 1.04-1.95)。
- LDL>3 mmol/L与Gleason 8-10癌风险升高相关(HR 1.38,95%CI 1.02-1.86)。
- 3年滞后分析中,总胆固醇>4.4 mmol/L(HR 1.27,95%CI 1.05-1.54)和>5.1 mmol/L(HR 1.26,95%CI 1.05-1.51)与总体前列腺癌风险升高相关。
- 3年滞后分析中,HDL最高三分位(HR 1.33,95%CI 1.08-1.64)和>1 mmol/L(HR 1.29,95%CI 1.01-1.65)与总体前列腺癌风险升高相关。
- 20年滞后分析中,总胆固醇最高三分位与前列腺癌风险降低相关;总体风险关联随滞后时间增加而增强,但仅在FinRSPC对照组中观察到。
临床怎么用
- 对于总胆固醇>5.1 mmol/L或LDL>3 mmol/L的男性,应关注Gleason 8-10前列腺癌的风险。
- 血脂参数与前列腺癌风险的关联受滞后时间影响,短期与长期关联方向可能不同。
- 他汀使用不影响血脂参数与前列腺癌的风险关联,不应据此调整风险评估。
局限性
- 研究为观察性嵌套人群分析,不能确立因果关系。
- 风险关联仅在FinRSPC对照组中观察到,可能限制普遍性。
- 血脂参数仅基线测量,未考虑随时间变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypercholesterolemia has been associated with advanced stage prostate cancer (PCa), but the role of lipid parameters such as HDL and triglycerides is unclear. We examined PCa risk by lipid parameters in a population nested within the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC). METHODS: Cholesterol measurements were available on 17,696 men. During the 17-year median follow-up, 2404 PCa cases were diagnosed. Cox regression model was used to estimate hazard ratios (HR) and their 95% confidence intervals (95% CI) for overall PCa risk and stratified by Gleason grade and tumor stage. We compared normolipidemic and hyperlipidemic men on four cholesterol parameters total cholesterol (TC), HDL, LDL, and triglycerides (TG), analyzed as time-dependent variables. RESULTS: TC in the highest tertile (above 5.1 mmol/l) and LDL above 3 mmol/l were associated with increased risk of Gleason 8-10 cancer (HR 1.42, 95% CI 1.04-1.95 and HR 1.38, 95% CI 1.02-1.86, respectively). Further, overall PCa risk was elevated in the 3-year lag time analysis by TC in the highest two tertiles (HR 1.27, 95% CI 1.05-1.54 for TC above 4.4 mmol/l, and HR 1.26, 95% CI 1.05-1.51 for TC above 5.1 mmol/l) and HDL in the highest tertile (HR 1.33, 95% CI 1.08-1.64) and above 1 mmol/l (HR 1.29, 95% CI 1.01-1.65). In contrast, TC in the highest tertile was associated with a decreased risk of PCa with 20-year lag time. The risk associations for overall PCa grew stronger with added lag time but were observed only in the FinRSPC control arm. Statin use did not modify the risk association. CONCLUSIONS: Hypercholesterolemia may increase overall PCa risk in short-term, inverse risk association was observed with 20-years' time lag. Similar risk increase of overall PCa was also observed for elevated HDL, conflicting with previous findings on the subject.
引用
- Murtola TJ, Kasurinen TVJ, Talala K, et al. Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer. Prostate Cancer Prostatic Dis. 2018. PMID: 30214034. doi:10.1038/s41391-018-0087-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。